Ansbert Gadicke - Director at Cullinan Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
CGEM on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Ansbert Gadicke since 11/5/2023

Holdings reported by Ansbert Gadicke for Cullinan Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 7.65M $95.3M $12.46 Dec 31, 2021 Indirect
Common Stock 595K $7.42M $12.46 Dec 21, 2021 Direct
Stock Option (Right to Buy) 0 Dec 21, 2021 Direct Common Stock

Transactions reported by Ansbert Gadicke for Cullinan Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.